Armata Pharmaceuticals Q4 EPS $(0.55) Misses $(0.35) Estimate, Sales $1.53M Beat $860.00K Estimate
Armata Pharmaceuticals Q4 EPS $(0.55) Misses $(0.35) Estimate, Sales $1.53M Beat $860.00K Estimate
Armata Pharmaceuticals第四季度每股收益美元（0.55）未达到预期（0.35）美元，153万美元销售额超过86.00万美元的预期
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.35) by 57.14 percent. This is a 89.66 percent decrease over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $1.53 million which beat the analyst consensus estimate of $860.00 thousand by 77.67 percent. This is a 45.39 percent increase over sales of $1.05 million the same period last year.
Armata Pharmicals（美国证券交易所股票代码：ARMP）公布的季度亏损为每股0.55美元，比分析师普遍预期的0.35美元（0.35美元）低57.14％。这比去年同期每股亏损0.29美元（0.29美元）下降了89.66％。该公司公布的季度销售额为153万美元，比分析师普遍预期的86万美元高出77.67％。这比去年同期的105万美元销售额增长了45.39％。